Investigational Site Number: 7240005

Madrid 28041

2 studies enrolling now · 7 studies all time

What they study most

Asthma, Hidradenitis Suppurativa, Non-relapsing Secondary Progressive Multiple Sclerosis, Plasma Cell Myeloma, Plasma Cell Myeloma Recurrent, Psoriasis, Wheezing

Studies at this site

• Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa — Recruiting now
• Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS) — Recruiting now
• Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma — Running, not enrolling
• SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling
• A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis — Completed
• Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) — Completed
• A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma — Completed